EcoDrugPlus

Ribosomal Protein S8

Ensembl ID : ENSSLDG00000007129
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSSLDG00000022240
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSSLDG00000017797
Gene Symbol: RPSA
4 Cross references
515 Possible Orthologues:

Ribosomal Protein Lateral Stalk Subunit P0

Ensembl ID : ENSSLDG00000018979
Gene Symbol: RPLP0
3 Cross references
398 Possible Orthologues:

Ribosomal Protein, Large, P1

Ensembl ID : ENSSLDG00000011985
Gene Symbol: RPLP1
1 Cross references
377 Possible Orthologues:

Secretin Receptor

Ensembl ID : ENSSLDG00000005282
Gene Symbol: SCTR
3 Cross references
130 Possible Orthologues:

Selectin P

Ensembl ID : ENSSLDG00000016053
Gene Symbol: SELP
1 Cross references
49 Possible Orthologues:

Serine/threonine-Protein Kinase A-Raf-Like

Ensembl ID : ENSSLDG00000012136
Gene Symbol: LOC111647945
3 Cross references
191 Possible Orthologues:

Serine/threonine-Protein Kinase Pak 4-Like

Ensembl ID : ENSSLDG00000008609
Gene Symbol: LOC111657969
3 Cross references
166 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSSLDG00000010280
Gene Symbol: LOC111653227
3 Cross references
246 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSSLDG00000018837
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSSLDG00000000489
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).